Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Lancet (London, England) · 2023 · 299 citations · Glenn Jaffe
Primary Open-Angle Glaucoma Preferred Practice Pattern®.
Ophthalmology · 2021 · 379 citations · Kelly Muir
TFOS DEWS III: Management and Therapy.
American journal of ophthalmology · 2025 · 97 citations · Esen Akpek
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025 · 127 citations · Heather Elizabeth Whitson
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Ophthalmology · 2024 · 135 citations · Glenn Jaffe
Progression of Myopia in School-Aged Children After COVID-19 Home Confinement.
JAMA ophthalmology · 2021 · 335 citations · Jiaxing Wang
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Ophthalmology · 2021 · 326 citations · Glenn Jaffe
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Ophthalmology · 2021 · 300 citations · Glenn Jaffe